 Jordan Hoffman
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Perfusion | 10 | 2024 | 192 | 4.030 |
Why?
| | Tissue and Organ Procurement | 13 | 2024 | 314 | 3.960 |
Why?
| | Organ Preservation | 10 | 2024 | 93 | 3.440 |
Why?
| | Heart Transplantation | 13 | 2024 | 714 | 3.100 |
Why?
| | Tissue Donors | 14 | 2024 | 415 | 1.660 |
Why?
| | Lichens | 2 | 2023 | 14 | 1.020 |
Why?
| | Lung Transplantation | 3 | 2024 | 282 | 0.970 |
Why?
| | Consensus | 3 | 2024 | 652 | 0.950 |
Why?
| | Organ Preservation Solutions | 1 | 2023 | 43 | 0.870 |
Why?
| | Primary Graft Dysfunction | 1 | 2023 | 30 | 0.860 |
Why?
| | Tissue and Organ Harvesting | 1 | 2024 | 76 | 0.860 |
Why?
| | Genome, Mitochondrial | 1 | 2023 | 27 | 0.820 |
Why?
| | Terminology as Topic | 1 | 2024 | 204 | 0.820 |
Why?
| | Cold Ischemia | 1 | 2021 | 29 | 0.730 |
Why?
| | Cardiac Surgical Procedures | 3 | 2024 | 504 | 0.710 |
Why?
| | Graft Rejection | 2 | 2023 | 576 | 0.610 |
Why?
| | Vascular Stiffness | 1 | 2023 | 480 | 0.590 |
Why?
| | Organ Transplantation | 4 | 2024 | 233 | 0.580 |
Why?
| | Heart Failure | 4 | 2023 | 2164 | 0.520 |
Why?
| | Thoracic Injuries | 1 | 2016 | 57 | 0.490 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2022 | 282 | 0.470 |
Why?
| | Ventricular Dysfunction, Right | 3 | 2022 | 228 | 0.470 |
Why?
| | Aorta, Thoracic | 1 | 2016 | 262 | 0.420 |
Why?
| | Graft Survival | 4 | 2024 | 543 | 0.410 |
Why?
| | Cardiopulmonary Resuscitation | 1 | 2016 | 260 | 0.410 |
Why?
| | Wounds, Nonpenetrating | 1 | 2016 | 283 | 0.400 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1890 | 0.390 |
Why?
| | Stents | 1 | 2016 | 523 | 0.370 |
Why?
| | Ventricular Function, Right | 3 | 2023 | 275 | 0.370 |
Why?
| | Humans | 35 | 2024 | 130305 | 0.360 |
Why?
| | Surgeons | 2 | 2024 | 279 | 0.320 |
Why?
| | Rectal Neoplasms | 1 | 2009 | 136 | 0.290 |
Why?
| | Rectum | 1 | 2009 | 170 | 0.290 |
Why?
| | Death | 3 | 2024 | 124 | 0.280 |
Why?
| | Adult | 13 | 2024 | 35711 | 0.280 |
Why?
| | Carcinoma | 1 | 2009 | 218 | 0.280 |
Why?
| | Brain Death | 2 | 2024 | 46 | 0.270 |
Why?
| | Heart Ventricles | 3 | 2021 | 782 | 0.270 |
Why?
| | Survival Analysis | 3 | 2021 | 1293 | 0.270 |
Why?
| | Retrospective Studies | 10 | 2024 | 14675 | 0.250 |
Why?
| | Heart-Assist Devices | 2 | 2021 | 537 | 0.240 |
Why?
| | Donor Selection | 1 | 2024 | 81 | 0.220 |
Why?
| | Synteny | 1 | 2023 | 16 | 0.210 |
Why?
| | Costs and Cost Analysis | 1 | 2024 | 213 | 0.210 |
Why?
| | Allografts | 1 | 2023 | 139 | 0.210 |
Why?
| | Shock | 1 | 2024 | 97 | 0.210 |
Why?
| | Benzofurans | 1 | 2022 | 20 | 0.200 |
Why?
| | Ascomycota | 1 | 2022 | 31 | 0.200 |
Why?
| | Heart-Lung Transplantation | 1 | 2022 | 10 | 0.200 |
Why?
| | Cardiac Catheterization | 2 | 2023 | 584 | 0.200 |
Why?
| | Prostatic Neoplasms | 1 | 2009 | 1004 | 0.190 |
Why?
| | Heart Valve Prosthesis | 1 | 2023 | 132 | 0.190 |
Why?
| | Follow-Up Studies | 4 | 2024 | 4961 | 0.180 |
Why?
| | Hepatitis C | 1 | 2023 | 235 | 0.180 |
Why?
| | Pulmonary Artery | 2 | 2023 | 1099 | 0.170 |
Why?
| | Cardiac Output | 1 | 2020 | 159 | 0.170 |
Why?
| | Middle Aged | 10 | 2024 | 31322 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2022 | 269 | 0.160 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2019 | 31 | 0.160 |
Why?
| | Human Embryonic Stem Cells | 1 | 2019 | 23 | 0.160 |
Why?
| | Waiting Lists | 1 | 2021 | 250 | 0.160 |
Why?
| | Biological Evolution | 1 | 2023 | 428 | 0.160 |
Why?
| | Myocardial Contraction | 1 | 2020 | 337 | 0.160 |
Why?
| | CpG Islands | 1 | 2019 | 152 | 0.160 |
Why?
| | Phylogeny | 1 | 2023 | 847 | 0.160 |
Why?
| | Vena Cava, Inferior | 1 | 2019 | 68 | 0.150 |
Why?
| | Glucose | 1 | 2023 | 989 | 0.150 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 150 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 319 | 0.150 |
Why?
| | Heart Atria | 1 | 2019 | 130 | 0.150 |
Why?
| | Predictive Value of Tests | 1 | 2023 | 1974 | 0.150 |
Why?
| | Male | 10 | 2024 | 63748 | 0.140 |
Why?
| | Treatment Outcome | 3 | 2024 | 10341 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2022 | 643 | 0.140 |
Why?
| | Aortography | 1 | 2016 | 51 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2022 | 673 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2019 | 1207 | 0.120 |
Why?
| | Female | 8 | 2024 | 68842 | 0.110 |
Why?
| | DNA Methylation | 1 | 2019 | 610 | 0.110 |
Why?
| | Time Factors | 2 | 2023 | 6615 | 0.110 |
Why?
| | United States | 7 | 2024 | 14110 | 0.110 |
Why?
| | Heart | 3 | 2023 | 654 | 0.110 |
Why?
| | Adolescent | 2 | 2023 | 20374 | 0.110 |
Why?
| | Blood Vessel Prosthesis Implantation | 1 | 2016 | 201 | 0.110 |
Why?
| | Insulin | 1 | 2023 | 2322 | 0.100 |
Why?
| | Trauma Centers | 1 | 2016 | 410 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2551 | 0.100 |
Why?
| | Prognosis | 2 | 2024 | 3830 | 0.100 |
Why?
| | Hemostatic Techniques | 1 | 2012 | 46 | 0.100 |
Why?
| | Blood Loss, Surgical | 1 | 2012 | 91 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3380 | 0.090 |
Why?
| | Endovascular Procedures | 1 | 2016 | 305 | 0.090 |
Why?
| | Risk Assessment | 2 | 2023 | 3310 | 0.090 |
Why?
| | Registries | 3 | 2024 | 1934 | 0.090 |
Why?
| | Hospital Mortality | 1 | 2016 | 860 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2028 | 0.090 |
Why?
| | Resuscitation | 1 | 2012 | 244 | 0.080 |
Why?
| | Pelvic Exenteration | 1 | 2009 | 11 | 0.080 |
Why?
| | Exercise | 1 | 2020 | 1941 | 0.080 |
Why?
| | Hemorrhage | 1 | 2012 | 671 | 0.070 |
Why?
| | Aged | 2 | 2024 | 22282 | 0.070 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 484 | 0.070 |
Why?
| | Stroke Volume | 2 | 2020 | 593 | 0.070 |
Why?
| | Colonoscopy | 1 | 2009 | 228 | 0.070 |
Why?
| | Cohort Studies | 1 | 2016 | 5431 | 0.060 |
Why?
| | Biopsy | 1 | 2009 | 1107 | 0.060 |
Why?
| | Young Adult | 1 | 2021 | 12404 | 0.060 |
Why?
| | Thoracic Surgical Procedures | 1 | 2024 | 69 | 0.050 |
Why?
| | Polyketide Synthases | 1 | 2022 | 5 | 0.050 |
Why?
| | Travel | 1 | 2023 | 123 | 0.050 |
Why?
| | Hepacivirus | 1 | 2023 | 235 | 0.050 |
Why?
| | Shock, Cardiogenic | 1 | 2022 | 61 | 0.050 |
Why?
| | Multigene Family | 1 | 2022 | 200 | 0.050 |
Why?
| | Child | 1 | 2021 | 20961 | 0.050 |
Why?
| | Coronary Angiography | 1 | 2023 | 345 | 0.050 |
Why?
| | Drainage | 1 | 2022 | 166 | 0.050 |
Why?
| | Chromatography, Liquid | 1 | 2022 | 375 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 396 | 0.040 |
Why?
| | Survival Rate | 1 | 2024 | 1904 | 0.040 |
Why?
| | Critical Care | 1 | 2024 | 559 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 231 | 0.040 |
Why?
| | Quality of Health Care | 1 | 2023 | 611 | 0.040 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 104 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1381 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2019 | 231 | 0.040 |
Why?
| | Exercise Test | 1 | 2020 | 622 | 0.040 |
Why?
| | Electrocardiography | 1 | 2020 | 615 | 0.040 |
Why?
| | Lysine | 1 | 2019 | 278 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2023 | 697 | 0.030 |
Why?
| | Cardiopulmonary Bypass | 1 | 2019 | 194 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2020 | 390 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 906 | 0.030 |
Why?
| | Base Sequence | 1 | 2019 | 2162 | 0.030 |
Why?
| | Blood Pressure | 1 | 2022 | 1753 | 0.030 |
Why?
| | Histones | 1 | 2019 | 589 | 0.030 |
Why?
| | Cell Line | 1 | 2019 | 2786 | 0.030 |
Why?
| | Liver | 1 | 2022 | 1846 | 0.030 |
Why?
| | Protein Binding | 1 | 2019 | 2120 | 0.030 |
Why?
| | Plasma Substitutes | 1 | 2012 | 3 | 0.030 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2012 | 8 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2012 | 37 | 0.030 |
Why?
| | Saline Solution, Hypertonic | 1 | 2012 | 40 | 0.020 |
Why?
| | Pandemics | 1 | 2021 | 1538 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2023 | 2511 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2024 | 5400 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2019 | 1896 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2012 | 136 | 0.020 |
Why?
| | Plasma | 1 | 2012 | 203 | 0.020 |
Why?
| | Erythrocyte Transfusion | 1 | 2012 | 186 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 826 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 9865 | 0.020 |
Why?
| | Mutation | 1 | 2019 | 3723 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2012 | 742 | 0.020 |
Why?
| | Hemodynamics | 1 | 2012 | 1099 | 0.020 |
Why?
| | Length of Stay | 1 | 2012 | 1135 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2012 | 3369 | 0.010 |
Why?
|
|
Hoffman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|